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Purpose: To investigate the possible association between tumor necrosis factor alpha (TNF-α)−308 G/A polymorphism
and pseudoexfoliation (PEX) glaucoma.
Methods: One hundred and ten Turkish PEX glaucoma patients and 110 healthy control subjects were enrolled in the
study. All participants underwent a complete ophthalmic examination. TNF-α−308 was genotyped by polymerase chain
reaction and restriction endonuclease analysis.
Results: We found a high prevalence of the G/G genotype in PEX glaucoma patients (OR=2.88, 95% CI 1.15–7.20). The
A polymorphic allele frequency was 3.2% in patients with PEX compared with 8.2% in controls (p=0.023).
Conclusions: Our results suggest that TNF-α−308 G/A genotype is not associated with PEX glaucoma. The −308G/A
variant may be a possible protective factor against PEX.
Glaucoma is characterized by a progressive loss of retinal
ganglion cells. A previous study suggests that tumor necrosis
factor alpha (TNF-α) may contribute to the disease process
[1]. Pseudoexfoliation (PEX) is the most common identifiable
cause of open-angle glaucoma [2]. The pathogenesis of PEX
is  still  uncertain.  PEX  is  associated  with  the  excessive
synthesis and deposition of an abnormal elastic microfibrillar
material in all tissues of the anterior segment of the eyes and
systemic tissues [3]. Excessive production and accumulation
of abnormal matrix components may be due to increased de
novo synthesis, decreased turnover of matrix components, or
both. The extracellular matrix turnover is mediated by matrix
metalloproteinases  (MMPs).  The  tissue  inhibitors  of
metalloproteinases (TIMPs) regulate the activity of MMPs
[4]. Both MMP and TIMP expression are affected by TNF-
α. An increased level of TNF-α might induce extra MMPs and/
or TIMPs [5]. The TNF-α gene polymorphisms at position
−308 and −238 are the best characterized polymorphisms and
have  been  demonstrated  to  influence  TNF-α  expression
[6].The G to A substitution at the −308 position of TNF-α
(TNF2 allele) also results in higher TNF-α production [7]. In
this study, we aimed to investigate the distribution of TNF-α
−308 gene polymorphism in patients with PEX glaucoma.
METHODS
This case-control study included 110 patients with unilateral
or bilateral PEX glaucoma, and 110 control subjects. The
control  group  and  PEX  patients  were  selected  from  the
General Ophthalmology Polyclinic and Glaucoma section,
respectively  (Department  of  Ophthalmology,  Ankara
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University  School  of  Medicine,  Ankara,  Turkey).  On
ophthalmologic  examination,  the  anterior  and  posterior
segments  of  all  the  cases  were  evaluated,  and  intraocular
pressures (IOP) were measured with Goldmann applanation
tonometry. The corneal endothelium, iris, and iris margins
were evaluated for pseudoexfoliative material before dilation,
and after dilation, the anterior lens surface was examined. To
evaluate  the  angle  for  pseudoexfoliative  material  and
increased pigmentation, we used gonioprisms. Criteria for
inclusion in normal subjects were IOP less than 22 mmHg,
normal visual fields, no evidence of glaucomatous changes in
optic disc, and no history of glaucoma or ocular hypertension
in  first-degree  relatives.  These  controls  had  no
pseudoexfoliative  material  at  the  anterior  lens  capsule  or
pupillary margin. Unilateral or bilateral PEX glaucoma was
diagnosed by the presence of PEX in the anterior segment,
elevated  intraocular  pressure  (>21mmHg),  typical
glaucomatous  optic  nerve  changes  (notching,  thinner
neuroretinal  rim,  and  increased  cup-to-disc  ratio),  and
glaucomatous visual field defects. All of the patients and
control  subjects  were  Turkish.  Patients  and  controls  were
informed of the experiment including a detailed explanation
of all the procedures and gave their consent. The study was
conducted in accordance with the principles of the Declaration
of Helsinki.
TNF-α−308 polymorphism: Venous blood samples were
taken from all participants. Genomic DNA was isolated from
peripheral blood by conventional phenol-chloroform method.
The polymerase chain reaction (PCR) method was described
in previous studies [8,9]. A 194 bp promoter region containing
the polymorphism site was amplified [10] by using primers 5′
−AAT GGA AAT AGG TTT TGA GGG T*CA T−3′ and 5′
−TCT CGG TTT CTT CTC CAT CGC−3′ in which T* was
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1815not in the genomic DNA sequence and was introduced to
create a potential BspHI site (New England Biolabs Inc.,
Ipswich,  MA).  PCR  was  performed  in  a  total  volume  of
50 μl containing 5 μl of DNA template, 1 U Taq polymerase
(Fermentas, Vilnius, Lithuania) in appropriate 10X buffer,
200 μM of dNTP each, 1.5 mM MgCl2, and 25 pM of each of
the  primers.  Cycling  conditions  were  as  follows:  initial
denaturation at 94 °C for 5 min followed by 35 cycles at 94 °C
denaturation for 30 s, 55 °C annealing for 30 s, and 72 °C
extension for 30 s. A final extension was performed at 72 °C
for 7 min. The product was electrophoresed in a 1% (wt/vol)
agarose gel, and bands were visualized under ultraviolet (UV)
after ethidium bromide staining.
To determine the A allele at position −308, 12.5 μl of the
PCR product was digested overnight with 10 U of the enzyme,
BspHI,  at  37  °C  and  electrophoresed  in  a  2.5%  (wt/vol)
agarose gel. This digestion results in an uncut 194 bp fragment
when G is present at −308 position and in two fragments of
169 bp and 25 bp when A (TNF2) is present.
Statistical analysis: Nominal variables were evaluated by
the  χ2  test,  and  the  odds  ratio  was  calculated.  Age  was
compared  between  groups  by  Student’s  t-test.  Allele
frequencies were determined by gene counting. To assess the
agreement between genotypes observed and those predicted
by the Hardy–Weinberg equilibrium, the likelihood ratio test
(G statistic) was used [11,12]. A sample size of 220 achieves
80% power to detect an effect size (W) of 0.19 using 1° of
freedom χ2 test with a significance level (α) of 0.05. A p value
less than 0.05 was considered statistically significant.
RESULTS
There were no statistically significant differences between the
ages and sex of the patients and controls (p=0.144, p=0.589,
respectively; Table 1). The distribution of the TNF-α G/A
polymorphism was in accordance with the Hardy–Weinberg
equilibrium  in  the  PEX  patients  with  glaucoma  and  the
controls (p=0.657, p=0.218, respectively). The distribution of
TNF-α G/A polymorphism between PEX glaucoma patients
and  controls  was  significantly  different  from  each  other
(p=0.019). The frequency of the GG genotype in the PEX
glaucoma group was higher than that of controls (OR=2.88,
95% CI 1.15–7.20; Table 2). The frequencies of the A and G
alleles  were  significantly  different  between  the  groups
(p=0.023; A=7 (3.2%), G=213 (96.8%) and A=18 (8.2%),
G=202  (91.8%)  for  PEX  glaucoma  and  control  groups,
respectively).
DISCUSSION
Progressive  accumulation  of  PEX  material  in  the
juxtacanalicular  tissue  causes  an  increase  in  intraocular
pressure in PEX syndrome [13,14]. The pathogenesis of an
aberrant  matrix  process  is  still  unknown.  Recent  studies
showed that lysil oxidase-like 1 gene polymorphisms were
highly associated with PEX [15-17].
MMPs and TIMPs can play a role in the development of
an  abnormal  extracellular  matrix  characteristic  of  PEX
syndrome/glaucoma and primary open-angle glaucoma [13,
14]. MMPs belongs to the endopeptidases family, and they
contribute to trabecular extracellular matrix degradation [18,
19]. TIMPs regulate the activity of the MMPs. An increased
level of TNF-α might induce extra MMPs and/or TIMPs [5].
The functional polymorphisms in the promoter region affect
plasma TNF-α levels. A G to A polymorphism at position –
308 of TNF-α is associated with elevated TNF levels [7]. It is
possible that another single nucleotide polymorphism (SNP)
might  be  within  TNF-α  that  is  more  relevant  to  TNF-α
production than the TNF-α−308 A allele. However, a neat
association  between  TNF-α  levels  and  TNF-α−308
polymorphism exists [20]. Therefore, other polymorphisms in
this gene could have less of an effect on TNF-α levels.
Lin et al. [21] evaluated the association between the TNF-
α-308  polymorphism  and  primary  open-angle  glaucoma
(POAG)  in  Chinese  patients.  They  determined  that  the
distribution of TNF-α−308 G/A was significantly higher in
the POAG patients. Mossbock et al. [22] concluded that allelic
frequencies and genotype distributions of the TNF-α−308G/
A  polymorphisms  did  not  significantly  differ  between
Caucasian  patients  with  POAG  and  control  subjects.
Funayama et al [23]. did not find significant difference in the
frequency of the TNF-α-308 G/A genotype between Japanese
patients with glaucoma (POAG or normal pressure glaucoma)
and healthy subjects.
In this study, we investigated the distribution of the TNF-
α−308  polymorphism  in  Turkish  PEX  glaucoma  patients.
TNF G/A genotype was also found to be lower in our PEX
glaucoma patients than in control subjects, we detected a high
prevalence of the G/G genotype in Turkish PEX glaucoma
patients. However, our main hypothesis was to demonstrate
the higher frequency of the GA genotype in PEX glaucoma
TABLE 1. DEMOGRAPHIC CHARACTERISTICS OF PARTICIPANTS.
Age (years) Mean±SD Female
n (%)
Male
n (%)
Total
(n)
PEX glaucoma 66.0±7.6 49 (44.5) 61 (55.5%) 110
Controls 64.2±10.1 53 (48.2) 57 (51.8) 110
p value 0.144 0.589
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1816patients.  To  our  knowledge,  this  is  the  first  study  that
evaluated the association between the TNF-α polymorphism
and PEX glaucoma. It is interesting that the TNF-α−308 A
allele frequency is similar to previous studies from Turkey in
different age groups [8,9,24]. Further, Turkish population is
an  admixture  of  several  Caucasian  individuals  who  have
emigrated from different parts of the world, but there is no
admixture with the Japanese and Chinese. The TNF-α-308 G/
A  polymorphism  has  been  studied  in  association  with
different  complex  diseases.  Although  increased  TNF-α
expression is linked to several diseases, some studies similar
to ours have reported opposite results. The exact etiology of
psoriasis is still unclear but the increased levels and activity
of proinflammatory cytokines, such as tumor necrosis factor
(TNF)-α  were  suggested  in  the  development  of  psoriasis
[25].  However,  Chunying  et  al.  [26]  performed  a  meta-
analysis, and they found there was a protective effect for the
−308G/A  variant  genotypes  compared  with  the  wild  type
homozygous  genotypes.  TNF-α  produces
hypertriglyceridemia mediated by decreased lipolysis, and
increased very density lipoproteins (VLDL) secretion [27].
Parra-Rojas et al. [28] detected that homozygous GG carriers
showed  significantly  higher  serum  triglycerides  than  GA
carriers. Pereira et al. [29] performed a meta-analysis for
ischemic  stroke,  and  they  showed  that  the  G-308A
polymorphism might be a protective factor against ischemic
stroke in Asians only.
In  our  study,  the  GG  genotype  was  higher  in  PEX
glaucoma patients than in healthy controls. In conclusion, we
could not find significant association between the 308 G/A
genotype and the susceptibility to PEX glaucoma. TNF-α
−308 G/G may be a genetic marker for identifying patients
with increased risk of PEX glaucoma. Exactly how the GG
polymorphism works to influence risk for PEX glaucoma
remains unknown. Probably the genetic background of our
population may be the reason for higher frequency of GG
genotype in PEX glaucoma. Further studies are needed to
confirm this finding.
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